You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 2, February 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Selective Immunological Evaluation of Mycosis Fungoides

Peter A. Cooperrider, MD; Henry H. Roenigk, Jr, MD

Arch Dermatol. 1978;114(2):207-212.


Abstract

• Tests of specific aspects of immune function were conducted on 15 patients with clinically and histologically evident mycosis fungoides of various stages. These tests included peripheral blood lymphocyte counts, T and B cell counts, mitogen stimulation tests to phytohemagglutinin (PHA), concanavalin A (con A), and pokeweed mitogen, as well as determinations of IgE levels and antinuclear factor (ANF). We found that mycosis fungoides patients, as a group, had normal peripheral blood lymphocyte, T cell, and B cell counts, but had decreased stimulation to PHA and con A. When evaluated by stage of disease, the peripheral blood lymphocytes, T and B cell counts did not differ significantly from normal, at least until stage V. Concanavalin A stimulation was decreased by stage II disease, and PHA was decreased by stage III, indicating at least a selective immunological deficit in the plaque stage or in later disease. Values of IgE and ANF were rarely abnormal.

(Arch Dermatol 114:207-212, 1978)



Author Affiliations

From the Department of Dermatology, Cleveland Clinic Foundation. Dr Cooperrider is now in private practice in Kirkland, Wash. Dr Roenigk is now with the Department of Dermatology, Northwestern University Medical School, Chicago.


Footnotes

Accepted for publication July 18, 1977.

Reprint requests to the Department of Dermatology, Northwestern University Medical School, 303 E Chicago Ave, Chicago, IL 60611 (Dr Roenigk).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Depressed Lymphokine Activated Killer Cell Activity in Mycosis Fungoides: A Possible Marker for Aggressive Disease
Wood et al.
Arch Dermatol 1990;126:907-913.
ABSTRACT  

Prolonged Remission of Tumor-Stage Mycosis Fungoides by Topical Immunotherapy
Vonderheid et al.
Arch Dermatol 1981;117:586-589.
ABSTRACT  

Cutaneous T-Cell Lymphomas: A Review of the Recent Literature
Zackheim
Arch Dermatol 1981;117:295-304.
ABSTRACT  

Chronic Herpes Simplex Infection in Cutaneous T-Cell Lymphomas
Vonderheid et al.
Arch Dermatol 1980;116:1018-1022.
ABSTRACT  

Herpes Zoster-Varicella in Cutaneous T-Cell Lymphomas
Vonderheid and van Voorst Vader
Arch Dermatol 1980;116:408-412.
ABSTRACT  

Immunologic Evaluation in Mycosis Fungoides: Before and After PUVA Therapy
Kubba et al.
Arch Dermatol 1980;116:178-181.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.